GeneDx Holdings (WGS) Total Debt Growth (3y) (2023 - 2026)
GeneDx Holdings (WGS) Total Debt Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | 10.14% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -4.73% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 5.11% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | -60.49% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | -0.64% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 9.58% |
| 10 | GeneDx Holdings | 2.03 Bn | 1.90 Bn | 78.24 Mn | 151.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 151.98% |
| Mar 31, 2026 | 111.53% |
| Dec 31, 2025 | 69.79% |
| Sep 30, 2025 | 63.80% |
| Jun 30, 2025 | 60.44% |
| Mar 31, 2025 | 57.34% |
| Dec 31, 2024 | 56.20% |
| Sep 30, 2024 | 61.19% |
| Jun 30, 2024 | 39.28% |
| Mar 31, 2024 | 39.41% |
| Dec 31, 2023 | 37.21% |